Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release by Indira Neeli & Marko Radic
“ﬁmmu-04-00038” — 2013/2/18 — 19:05 — page 1 — #1
ORIGINAL RESEARCH ARTICLE
published: 20 February 2013
doi: 10.3389/ﬁmmu.2013.00038
Opposition between PKC isoforms regulates histone
deimination and neutrophil extracellular chromatin release
Indira Neeli and Marko Radic*
Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA
Edited by:
Mariana J. Kaplan, University of
Michigan, USA
Reviewed by:
Huw Lewis, GlaxoSmithKline, UK
Carmelo Carmona-Rivera, University
of Michigan, USA
*Correspondence:
Marko Radic, Department of
Microbiology, Immunology and
Biochemistry, University of Tennessee
Health Science Center, 858 Madison
Avenue, Memphis, TN 38163, USA.
e-mail: mradic@uthsc.edu
In response to inﬂammation, neutrophils deiminate histones and externalize chromatin.
Neutrophil extracellular traps (NETs) are an innate immune defense mechanism, yet
NETs also may aggravate chronic inﬂammatory and autoimmune disorders. Activation
of peptidylarginine deiminase 4 (PAD4) is associated with NET release (NETosis) but
the precise mechanisms of PAD4 regulation are unknown. We observed that, in human
neutrophils, calcium ionophore induced histone deimination, whereas phorbol myristate
acetate (PMA), an activator of protein kinase C (PKC), suppressed ionophore-induced
deimination. Conversely, low doses of chelerythrine and sanguinarine, two inhibitors of
PKC, reversed PMA inhibition and enhanced ionophore-stimulated deimination. In addition,
a peptide inhibitor of PKCα superinduced ionophore activation of PAD4, thus identifying
PKCα as the PMA-induced inhibitor of PAD4. At higher doses, chelerythrine, sanguinarine,
and structurally unrelated PKC inhibitors blocked histone deimination, suggesting that a
different PKC isoform activates histone deimination.We identify PKCζ as activator of PAD4
because a speciﬁc peptide inhibitor of this PKC isoform suppressed histone deimination.
Confocal microscopy conﬁrmed that, in the presence of PMA, NETosis proceeds without
detectable histone deimination, and that ionophore cooperates with PMA to induce more
extensive NET release. Broad inhibition of PKC by chelerythrine or speciﬁc inhibition of
PKCζ suppressed NETosis. Our observations thus reveal an intricate antagonism between
PKC isoforms in the regulation of histone deimination, identify a dominant role for PKCα
in the repression of histone deimination, and assign essential functions to PKCζ in the
activation of PAD4 and the execution of NETosis. The precise balance between opposing
PKC isoforms in the regulation of NETosis afﬁrms the idea that NET release underlies
speciﬁc and vitally important evolutionary selection pressures.
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INTRODUCTION
Neutrophils are the ﬁrst responders of the innate immune sys-
tem (Nathan, 2006). By their rapid and effective response to
infections, neutrophils perform an essential role in the defense
of the host from various pathogens. Neutrophils circulate in the
blood which carries them to the site of an infection. Within sec-
onds, they adhere to the activated endothelium and pass through
or between endothelial cells into tissues (Phillipson et al., 2006).
There, neutrophilsmigrate along gradients of inﬂammatorymedi-
ators toward the ongoing infection. Upon arrival, they engage
bacteria, viruses, or fungi through alternative and complementary
mechanisms, including phagocytosis, production of reactive oxy-
gen, and the secretion of bactericidal substances (Kennedy and
DeLeo, 2009). Despite the vital role of neutrophil responses to
infections, we have only an incomplete understanding of neu-
trophil functions. The study of neutrophils ex vivo is complicated
by their short lifetime and the difﬁculty of recreating characteris-
tics of an infection in a culture dish. Pharmacological stimuli that
are capable of eliciting neutrophil activation in vitro are therefore
widely used in the analysis of neutrophil responses to infections.
Phorbol-12-myristate-13-acetate (PMA) is useful for its ability
to activate neutrophils and elicit responses that include enhanced
adhesion, production of reactive oxygen, and degranulation
(Tauber, 1987). PMA elicits these responses because it can pene-
trate the cellmembrane andmimic diacylglycerol (DAG), a cellular
signal that activates two of the three families of protein kinase C
(PKC). The PMA-responsive PKC belong to the classical (α, β,
γ) and novel (δ, υ, τ) PKC families, whereas the alternative PKC
isoforms (ζ, λ/ι) function independent of DAG/PMA (Steinberg,
2008). The classical PKC are distinguished from all other PKC
because they also require elevated calcium for maximal activity.
The compounds A23187 and ionomycin serve as ionophores that
form channels in the plasma membrane and allow inﬂux of cal-
cium ions (Erdahl et al., 1994). In many studies, ionophores are
used in combination with PMA to elicit maximal activation of
cellular responses that require elevated intracellular calcium and
PKC activation.
Phorbol myristate acetate and ionophore are strong stimuli
for multiple pathways in neutrophils. Thus, a plausible predic-
tion was that PMA or ionophore would affect the manner in
which neutrophils die. PMA induces a unique cell death that dif-
fers from apoptosis and necrosis (Takei et al., 1996; Suzuki and
Namiki, 1998). The discovery that this novel form of neutrophil
cell death involves the release of nuclear chromatin and serves in
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the innate neutrophil response to pathogens (Brinkmann et al.,
2004) led to a fundamental paradigm shift in our thinking about
innate immune responses to infections. Indeed, the cell death that
is induced by PMA is in many ways analogous to the response of
neutrophils to bacterial, fungal, protozoan, and viral pathogens
(Brinkmann and Zychlinsky, 2012). Thus, PMA found a new use
in studies on the mechanisms of neutrophil innate responses to
pathogens.
When exposed to pathogens, or to particulates in the pres-
ence of inﬂammatory stimuli, neutrophils decondense chromatin,
and rupture the nuclear envelope which allows the nuclear chro-
matin to expand into the cytoplasm (Fuchs et al., 2007). In parallel,
cytoplasmic granules burst, releasing bactericidal contents into
the cytoplasm where they associate in a tight complex with the
unraveling chromatin. The last and most dramatic step in this
programed cell death pathway is the release of chromatin to the
extracellular space. The externalized chromatin can immobilize
pathogens and is therefore referred to as a neutrophil extracellular
trap (NET). The cell death resulting in NET chromatin release is
called NETosis (Steinberg and Grinstein, 2007). A variant form
of NETs is composed of mitochondrial DNA and their release
may not lead to cell death (Youseﬁ et al., 2009). Indeed, in vivo
observations in mice infected by S. aureus indicate that release
of nuclear chromatin NETs may not induce the immediate loss
of cellular functions (Yipp et al., 2012), although functions that
depend on gene expression are presumably compromised in these
neutrophils.
The release of chromatin follows the activation of peptidy-
larginine deiminase 4 (PAD4), an enzyme that converts arginine
residues to citrullines (Neeli et al., 2008;Wang et al., 2009). PAD4 is
activated by inﬂammatory stimuli and bacterial breakdown prod-
ucts (Neeli et al., 2008). Its activation depends on signals from
the cell surface and on an intact cytoskeleton (Neeli et al., 2009).
Of the ﬁve mammalian deiminases, PAD4 is the enzyme that
localizes to the nucleus and modiﬁes histones (Nakashima et al.,
2002). Because mutant mouse neutrophils that lack PAD4 cannot
release NETs (Li et al., 2010; Hemmers et al., 2011), it has been
argued that NET release depends on the activity of PAD4. Just
how PAD4 mediates NET release is not known. One possibility is
that deimination serves a structural role in the global relaxation
of chromatin that precedes NET release: deimination reduces the
positive charge of histones which may unravel the tightly packed
nuclear chromatin andpromoteNETosis (Wang et al.,2009). Alter-
natively, deimination could reprogram gene expression in analogy
with other post-translational modiﬁcation (PTM) and thus set
the stage for the execution of NETosis in response to inﬂam-
mation (Cuthbert et al., 2004; Wang et al., 2004). To distinguish
between these possibilities, we must learn more about the regula-
tion of PAD4 in neutrophils. Here, we report consequences of PKC
isoform activation and repression on histone deimination and
NETosis.
MATERIALS AND METHODS
ANTIBODIES AND CHEMICALS
We obtained the rabbit antibody (Ab) to the carboxy terminus
of histone H3 and the Ab to modiﬁed citrulline from Millipore
(Temecula, CA, USA). The rabbit Ab to deiminated histone H3
(dH3) was from Abcam (ab 5103). The horseradish peroxidase
(HRP)-conjugated secondary Abs to rabbit immunoglobulin G
(IgG; A0545), goat anti-rabbit conjugated to AF488, calcium
ionophore (A23187), ionomycin (I0634), PMA (P8139), and
protease inhibitor cocktail (P8340) were purchased from Sigma-
Aldrich. Sytox orange was obtained from Invitrogen Life Tech-
nologies. All enzyme inhibitors used in this paper were purchased
from Calbiochem (Millipore).
HUMAN NEUTROPHIL ISOLATION
Neutrophils were isolated from buffy coats obtained from healthy
donors (Lifeblood Biological Services, Memphis, TN, USA) in
accord with protocols approved by the University of Tennessee
Institutional ReviewBoard and isolated followingpublishedmeth-
ods (Neeli et al., 2008). Brieﬂy, neutrophils were puriﬁed at room
temperature (RT), enriched in the supernatant of an Isolymph
sedimentation and recovered in the pellet of an Isolymph density
gradient (Gallard Schlesinger) under endotoxin-free conditions.
The contaminating erythrocytes were lysed in ice-cold hypotonic
(0.2%) sodium chloride solution for 30 s, at which point the solu-
tion was rendered physiologic saline by addition of hypertonic
(1.6%) sodium chloride. The neutrophils were rinsed once in
Hanks’ balanced salt solution (HBSS; without calcium or mag-
nesium) and re-suspended at 2 × 106 cells/ml. At that point,
neutrophil viability was assessed by trypan blue dye exclusion and
exceeded 98%. Neutrophils were kept at RT (for up to 30 min)
before use in experiments.
TREATMENTS OF NEUTROPHILS AND DETERMINATION OF HISTONE
DEIMINATION
One million cells in 500 μl of HBSS were incubated in polypropy-
lene tubes with or without different inhibitors for 30 min at 37◦C.
Then, 2× stimuliwere added in 500μl of HBSS containing 200μM
calcium. For lipopolysaccharide (LPS) stimulation, we added 1%
human serum as a source of LPS-binding protein to phosphate
buffered saline (PBS) containing 100 μM calcium and 100 ng/ml
LPS. Following 2 h of incubation, the cells were centrifuged at
1200 rpm for 5 min, the buffer was discarded and the cell pellet
was lysed by adding 50 μl of sodium dodecyl sulfate (SDS) lysis
buffer. Samples were boiled for 5min, cooled and stored at−20◦C
until use.
PREPARATION AND ANALYSIS OF NETs
To prepare NETs, 1 × 106 puriﬁed neutrophils were plated in
500μl of serum-free HBSS containing 100μMCaCl2 per well in a
24-well tissue culture plate. Ionophore, PMA or a combination of
the two compounds were added as stimuli to induce NETosis. At
the end of 1, 2, or 4 h incubations, 0.5 U of micrococcal nuclease
(Worthington) was added to the wells and the plate was incu-
bated for another 10 min at 37◦C. Supernatants were collected
and adjusted to 2 mM ethylenediaminetetraacetic acid (EDTA),
clariﬁed by centrifugation at 5,000 g for 5 min, and saved for anal-
ysis of DNA and myeloperoxidase (MPO). DNA concentrations
were determined by Pico-Green ﬂuorescence (“Quant-It,” Life
Technologies). MPO activity was measured in parallel aliquots by
oxidation of tetramethylbenzidine (TMB, 2 mM) in the presence
of H2O2, followed by spectrophotometry.
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WESTERN BLOTTING
Cell lysates were resolved by 12% SDS-PAGE (polyacrylamide gel
electrophoresis), and blotted to nitrocellulose membranes. Mem-
branes were blocked for 1 h at RT with 5% bovine serum albumin
(BSA) or 5%milk in TBST [Tris-buffered saline (TBS) and Tween
20, 25 mM Tris (pH 7.2), 150 mM NaCl, and 0.1% Tween 20]
and rinsed before overnight incubation at 4◦C with a dilution
of primary Abs in TBST. Subsequently, membranes were washed
and incubated for 1 h with goat anti-rabbit Ab conjugated to HRP,
washed three timeswith TBST and twicewith TBS alone. TheHRP
activity was detected by using chemiluminescence reagent plus
(PerkinElmer Life Sciences) and exposure to autoradiographic
ﬁlm. For detection of citrullines, membranes were blocked with
1% ovalbumin and incubated with chemical reagents that modify
citrulline by formation of an ureido group, as suggested by the
manufacturer.
CONFOCAL MICROSCOPY
Neutrophils were allowed to settle for 30 min at 37◦C onto glass
coverslips that were precoated with poly-L-lysine. The cells were
treatedwith stimuli in the presence or absence of various inhibitors
(or left untreated) and incubated for 2 h at 37◦C. The coverslips
were washed with ice-cold HBSS, the cells were ﬁxed with 4%
paraformaldehyde in HBSS and blocked 1 hr at RT with blocking
solution (HBSS with 1%BSA, 0.05%Tween 20, and 2mMEDTA).
The coverslipswerewashedwithwashbuffer (HBSSwith 1%BSA),
incubated with rabbit anti-citrullinated histone H3 Abs (diluted
1/100 in wash buffer), washed again, incubated with goat anti-
rabbit IgG coupled with AF488 together with Sytox orange for
30 min at RT, and analyzed by confocal microscopy, as previously
described. Viability of neutrophils exposed to various inhibitors
was assessed by trypan blue exclusion following a 2-h incubation.
Cell viability ranged between 90 and 95% for any of the inhibitors
at the highest concentrations used in our assays. The exception
was calphostin C that at 100 μM reduced viability of treated cells
to 80%.
RESULTS
DISTINCT EFFECTS OF NEUTROPHIL ACTIVATORS ON HISTONE
DEIMINATION AND NET RELEASE
A wide variety of inﬂammatory stimuli induce histone deimina-
tion and NET release (Rohrbach et al., 2012). Quite commonly,
PMA or the A23187 ionophore have been used as stimuli for
NETosis. Hence, we wished to determine the extent of histone
deimination following administration of these compounds to
puriﬁed human neutrophils.We also set out to determine whether
the two stimuli can be used in combination. In buffers that
contained 100 μM calcium, ionophore strongly induced histone
deimination (Figure 1A). In contrast, PMA did not increase his-
tone deimination above background. Instead, PMA diminished
the low level of histone deimination that was induced by calcium
alone. Strikingly, PMA reduced ionophore-induced deimination
to background levels when the two were added simultaneously to
neutrophils. To exclude the possibility that PMA induces a cit-
rulline distribution in histone H3 that escapes detection by the
anti-citrullinated H3 reagent, we probed a duplicate blot with an
Ab that recognizes modiﬁed citrullines (Figure 1B). This reagent
conﬁrmed that PMA treatment does not induce deimination of
any proteins in the cell and that ionophore treatment results
in the deimination of histones H3 and H4 as the predominant
PAD4 substrates. At 2 h after PMA addition, one additional band
was detected at approximately 50 kD (Figure 1B). This band
may correspond to the previously identiﬁed PAD2 substrate actin
(Darrah et al., 2012). We must insert a cautionary note here: cer-
tain modiﬁcations may remain below the detection limit of the
reagents we used to detect modiﬁed citrullines. However, it is
valid to point out that the reagents clearly detect citrulline in
lysates from ionophore treated neutrophils. Thus, PMA does not
induce histone deimination that is detected by histone-speciﬁc or
by modiﬁed citrulline-speciﬁc antibodies.
Suppression of deimination by PMA was observed in differ-
ent physiological buffers and with different calcium ionophores.
In PBS or HBSS (each supplemented to 100 μM calcium), the
A23187 ionophore induced histone deimination that was inhib-
ited to background levels by PMA (Figure 1C). Substitution of
ionomycin for A23187 (in HBSS buffer) induced deimination that
was greatly diminished by addition of PMA (Figure 1C). These
results indicate that an increase in cytoplasmic calcium stimulates
histone deimination by PAD4 but that a target of PMA, presum-
ably a PMA-dependent PKC isoform, acts in a dominant fashion
to suppress deimination.
Because most stimuli for histone deimination also induce
NETosis (Neeli et al., 2009), we decided to test whether PMA and
ionophore, separately or combined, induce NETosis. Untreated,
freshly isolated neutrophils displayed multilobed nuclei of uni-
form size (Figure 1D). Upon incubation with PMA,nuclei swelled
and constrictions between the nuclear lobes widened. Some nuclei
released their chromatin into the cytoplasm and other cells dis-
persed NETs (Figure 1E). In agreement with western blot results,
NETs induced by PMA contained very little or no dH3. The NETs
shown here (indicated by arrow heads in Figures 1E,G) resemble
the diffuse and cloud-like structures seen by live-cell microscopy
(Fuchs et al., 2007) or followingminimal ﬁxation of cells (Hakkim
et al., 2011; Brinkmann and Zychlinsky, 2012), leading us to con-
clude thatNETs acquire the extended, ﬁbrous structure after buffer
exchange and cover slip manipulations that are common steps in
cell ﬁxation protocols.
A23187 ionophore induced deimination that, in many neu-
trophils, coincided with nuclear swelling and chromatin release
(Figure 1F). In contrast, ionophore in combination with PMA
readily induced NETosis, yet histone deimination was below our
ability to detect (Figure 1G). Microscopy thus indicated that
A23187 ionophore or PMA, as well as the combination of the two
compounds, efﬁciently induce NETosis, which, in the presence
of PMA, proceeds with no detectable histone deimination. The
microscopy experiments thus suggested that histone deimination
may be dispensable for PMA-induced NETosis.
To quantify NET release induced by different treatments, we
solubilized NETs with micrococcal nuclease to measure DNA by
ﬂuorescence (Figure 1H) and released MPO by enzymatic reac-
tion (Figure 1I). ExternalizedMPO correlates with NET release as
most of the MPO is NET-associated (Parker et al., 2012a). In our
assays, DNA and MPO measurements concordantly showed that
ionophore or PMA induce NETosis but that a combination of the
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FIGURE 1 | Phorbol myristate acetate (PMA) suppresses histone
deimination, whereas ionophore or ionomycin stimulate deimination.
Puriﬁed neutrophils were incubated in buffers containing calcium (Ca),
A23187 ionophore (Io) or ionomycin (Im), and/or PMA for 2 h. Cells were
lysed and analyzed by western blotting to detect deiminated histone H3
(dH3) vs. total H3 (tH3). The presence of stimuli is indicated by a plus sign.
(Continued)
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FIGURE 1 | Continued
Panels (A,B) show blots of lysates from cells incubated with the indicated
stimuli or calcium alone. Panel (A) shows results of a blot detecting dH3,
whereas panel (B) shows antibody binding to modiﬁed citrullines. Migration
of H3 and H4 histones and position of molecular weight markers are
indicated. Asterisk indicates a protein of approximately 50 kD that is
deiminated in response to ionophore treatment. Substitution of PBS for
HBSS did not qualitatively alter the results of the treatments (C, top), nor
did substitution of ionomycin for ionophore (C, bottom). The highest levels
of dH3 were observed after ionophore or ionomycin treatment. Inclusion of
PMA reduced histone deimination and PMA alone failed to stimulate
deimination. Microscopy of unstimulated neutrophils showed cells with
multilobed nuclei (D), whereas PMA treatment induced nuclear swelling,
rupture, and NET release (E). In these pictures, DNA is displayed in blue and
binding of antibodies to deiminated histone H3 in green. Diffuse NETs are
indicated by arrow heads here and in (G). Ionophore induced histone
deimination in cytoplasm and decondensed nuclei (F). A combination of
PMA and ionophore led to enhanced NETosis with little to no detectable
histone deimination (G). Puriﬁed NET DNA was solubilized by micrococcal
nuclease digestion and quantiﬁed by ﬂuorescence (H). MPO released by
nuclease treatment was measured in solution by theTMB method (I). All
experiments were performed at least ﬁve times with consistent results.
two stimuli is evenmore effective at elicitingNETosis. These assays
conﬁrmed that the two stimuli cooperate in inducing NETosis,
whereas PMA counteracts ionophore in the induction of histone
deimination.
PMA INDUCES A PKC ISOFORM THAT SUPPRESSES HISTONE
DEIMINATION
Phorbol myristate acetate inhibition of histone deimination may
be mediated by a PMA-induced PKC isoform. To test whether
PAD4 inhibition could be relieved by repression of the inhibitory
PKC, we measured histone deimination in cells treated with PKC
inhibitors prior to stimulation with PMA. Indeed, we identi-
ﬁed a relatively narrow concentration range of chelerythrine, a
plant alkaloid (Powell and Chen, 1955), that could relieve the
repression of histone deimination by PMA. To conﬁrm this possi-
bility, we used the related compound sanguinarine (Schenck and
Hannse, 1954) and observed that, in the presence of ionophore,
5 μM chelerythrine or 1 μM sanguinarine optimally reversed
PMA inhibition (Figure 2A). Higher concentrations of the PKC
inhibitors (20 μM chelerythrine or 10 μM sanguinarine), how-
ever, suppressed deimination. These results suggested that PMA
induces, and low concentrations of these PKC inhibitors suppress,
a PKC isoform that inhibits histone deimination. Once this iso-
form is repressed, histone deimination again becomes inducible
by calcium ionophore.
To testwhether ionophore activates the inhibitoryPKC isoform,
we added low concentrations of chelerythrine and sanguinar-
ine prior to initiating ionophore treatment of neutrophils. We
used this experiment to ﬁne-tune the dose at which chelerythrine
and sanguinarine were most effective. Inhibitor concentrations
falling between 2.5 and 5.0 μM chelerythrine and near 2.5 μM
sanguinarine further enhanced ionophore-induced histone deim-
ination (Figure 2B). These results indicated that an elevation of
intracellular calcium activates the inhibitory PKC. Because classi-
cal PKC isoforms respond to calcium and PMA (Steinberg, 2008),
we deduced that the inhibitory PKC isoform is likely a member of
the classical group of PKC enzymes. As above, higher levels of the
FIGURE 2 | Conditions in which PKC inhibitors enhance histone
deimination. (A) Histone deimination that is repressed by PMA can be
derepressed by 5 μM chelerythrine (Chel) or 1 μM sanguinarine (Sang) but
higher concentrations of these inhibitors lead to renewed repression.
Levels of deiminated histone H3 (dH3) vs. total H3 (tH3) were estimated by
western blotting. (B) A narrow range of inhibitor concentrations also
superinduced histone deimination in response to ionophore (Io). (C)
Pseudosubstrate peptide inhibitor for PKCα/β enhanced histone
deimination that was stimulated by ionophore. The vertical white lines
separate lanes from the same gel that were taken with identical
autoradiographic exposure but were arranged differently in the original gel.
The presence of stimuli is indicated by a plus sign.
PKC inhibitors, or EDTA added to the medium (data not shown),
suppressed deimination.
Because neutrophils express PKCα (Nixon andMcPhail, 1999),
we repeated the ionophore stimulation in the presence of a speciﬁc
PKCα/β inhibitor peptide. The myristoylated inhibitor peptide
passes the plasma membrane and interacts with the catalytic
domain of the classical PKC isoform. The peptide inhibits sub-
strate binding, thus acting as a competitive inhibitor. Addition
of the PKCα/β inhibitory peptide increased the extent of histone
deimination induced by ionophore (Figure 2C), suggesting that
PKCα inhibits histone deimination.
PKCζ IS REQUIRED FOR INDUCTION OF HISTONE DEIMINATION
The inhibition of histone deimination by high levels of chelery-
thrine and sanguinarine (Figures 2A,B) suggested that histone
deimination is contingent on the activation of a second PKC
isoform. This possibility was consistent with our previous obser-
vation that treatment of neutrophils with staurosporine, a potent
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PKC inhibitor, blocks histone deimination (Neeli et al., 2008). To
conﬁrm the contribution of a PKC to deimination, we treated
neutrophils with calcium ionophore in the presence or absence of
additional, broadly effective PKC inhibitors. Pretreatment of neu-
trophils with calphostin C (Figure 3A) or bisindolylmaleimide 1
(BIM1; Figure 3B) diminished but failed to completely inhibit
the induction of histone deimination by calcium ionophore.
Calphostin C and BIM1 are considered relatively ineffective
for atypical PKC isoforms (Martiny-Baron et al., 1993; Xu and
Clark, 1997).
To pinpoint the PKC isoform that promotes histone deimina-
tion, we used peptide inhibitors of PKCτ and PKCζ, two PKC
isoforms that have been implicated in neutrophil responses to
external stimuli (Laudanna et al., 1998; Bertram et al., 2012). The
PKCζ inhibitor completely blocked histone deimination, whereas
the PKCτ peptide was ineffective (Figure 3C). These results indi-
cated that activation of histone deimination by calcium ionophore
depends on the activation of PKCζ.
To test whether PKC isoforms regulate histone deimination
induced by stimuli encountered in vivo, we incubated neutrophils
with speciﬁc PKC isoform inhibitors prior to stimulation with
LPS (Figure 3D). LPS treatment induced histone deimination
that could be suppressed by a peptide inhibitor of PKCζ, whereas
peptides against PKCα/β or PKCτ were ineffective at suppress-
ing LPS-induced PAD4 activation. This observation suggested
that PAD4 activation by PKCζ is a shared signal among diverse
neutrophil stimuli.
EFFECT OF PKC INHIBITORS ON NETosis
To examine the effect of enhanced vs. inhibited histone deimi-
nation on the morphology of NETosis, we incubated neutrophils
in the presence of various inhibitors prior to stimulation with
calcium ionophore. With chelerythine, we observed two differ-
ent results, depending on the concentration of inhibitor that was
used. At 5 μM chelerythrine, neutrophils generated increased lev-
els of deiminated histones and progressed through various stages
of NETosis (Figure 4A). Interestingly, we detected the highest lev-
els of dH3 in the cytoplasm of neutrophils with decondensing
nuclei and the levels remained high in cells with mixed nuclear
and cytoplasmic contents. In contrast, neutrophils incubated with
20 μM chelerythrine exhibited drastically reduced histone deimi-
nation, and cellmorphologies associatedwithNETosiswere largely
FIGURE 3 | Histone deimination induced by ionophore is only partially
suppressed by calphostin C or bisindolylmaleimide 1 (BIM1) but is fully
suppressed by a specific peptide inhibitor of PKCζ. Calphostin C (Calp)
partially suppressed histone deimination (A), as did addition of 100 nM BIM1
(B). These two compounds do not effectively block atypical PKC isoforms. In
contrast, ionophore-induced histone deimination was completely suppressed
by a peptide inhibitor of PKCζ but not by an inhibitor of PKCτ (C). The vertical
white lines separate lanes from the same gel that were taken with identical
autoradiographic exposure but were arranged differently in the original gel.
The presence of stimuli is indicated by a plus sign. Addition of LPS in PBS
(100 ng/ml) enhanced histone deimination, and a peptide inhibitor of PKCζ but
not of PKCτ or α/β suppressed the elevated level of deimination (D).
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FIGURE 4 | Effect of PKC inhibitors on NETosis. Neutrophils were
incubated with A23187 ionophore in the presence of 5 μM chelerythrine
(A), or 20 μM chelerythrine (B). Antibody binding to deiminated histone H3
(green) and the DNA contained in cells or released as NETs (blue) was
observed in 5 μM chelerythrine, whereas 20 μM inhibitor precluded
deimination and most other morphologic features of NETosis. Cells incubated
with PKCα/β pseudosubstrate peptide inhibitor deiminated histone H3 and
proceeded to NET release (C). The PKCζ inhibitor peptide suppressed histone
deimination and NET release but earlier stages of NETosis, such as a partial
heterochromatin decondensation and nuclear de lobulation, were observed
(D). As in Figure 1E, untreated neutrophils showed typical multilobed nuclei
without apparent evidence of NETosis (E).
absent (Figure 4B). Therefore, at the lower concentration of
chelerythrine, histone deimination and NETosis execution were
strongly induced, whereas, at the higher concentration of this
PKC inhibitor, both histone deimination andNETosis were largely
repressed.
The peptide inhibitors had dramatic effects on histone deimi-
nation and NET release. Exposure to the PKCα/β pseudosubstrate
inhibitor prior to stimulation by ionophore induced strong his-
tone deimination that was most notable in cells with decondensed
and expanded nuclei (Figure 4C). Importantly, neutrophils
stimulated with ionophore in the presence of PKCα inhibitor,
readily completed NETosis. In contrast, neutrophils treated with
PKCζ inhibitor showed dramatically decreased deimination and
impairedNETosis (Figure 4D).We observed early nuclear changes
of NETosis, such as nuclei with widened interlobe constrictions,
yet the release of NETs was largely repressed and cells resembled
neutrophils that were left untreated (Figure 4E). Collectively, these
results indicate that PKC inhibitors provide versatile tools for the
analysis of enzymatic steps that regulate the transitions in nuclear
structure during NETosis.
DISCUSSION
NETosis brings high risks and high rewards for the host
(Brinkmann and Zychlinsky, 2012; Kaplan andRadic, 2012). NETs
represent an efﬁcient mechanism to immobilize a broad range
of pathogens and expose them to a high local concentration of
damaging and potentially lethal compounds. Thus, NETs may
be a life-saving antimicrobial response. NETs also interface with
other granulocyte responses and thus establish an integrated set
of defenses against infections. However, the release of NETs along
with tissue degrading compounds from granulocytes at the site
of an infection has long been recognized as a risky strategy that
can damage host tissues (Nathan, 2006). An added risk to the host
arises from the contribution of NETs to blood clotting and the
formation of thrombi (Fuchs et al., 2010). Therefore, it is vital that
the release of NETs be carefully regulated.
One way to regulate NETosis is through regulation of PAD4.
PAD4 is intensely induced by inﬂammation, such that up to one-
ﬁfth of all histones in the cell acquire citrullines (Nakashima et al.,
2002). Most PAD4 substrate arginines are localized to the ﬂexible
histone amino termini that are important for nucleosome stacking
and histone DNA interactions. Loss of the positive charges along
the histone termini reduces electrostatic interactions with DNA
and thus allows chromatin to assume an extended conformation
(Leshner et al., 2012). The activation of PAD4 hence may provide
the mechanical lever whose mass action drives the major mor-
phologic transformation seen in NETosis. This view is consistent
with the severely impaired ability of PAD4-deﬁcient neutrophils to
initiate NETosis (Li et al., 2010; Hemmers et al., 2011). Although
PAD4 has numerous substrates in the cell, including PAD4 itself
(Andrade et al., 2010), modiﬁcation of core histones may be the
major reason for chromatin decondensation and NET release.
However, our study indicates that PMA-induced NETosis unfolds
in the absence of detectable histone deimination. This ﬁnd-
ing was unexpected because inﬂammatory and infection-related
stimuli for NETosis that invariably induce both the deimination
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of histones and the release of NETs. It seems likely that the PMA
signal for NETosis is qualitatively different from more physiologic
stimuli (Parker et al., 2012b). Nevertheless, it is remarkable that a
NET stimulus as potent as PMA induces NETs without apparent
activation of PAD4. Thus, it is important to more clearly under-
stand the regulation and consequences of PAD4 activation in the
induction of NETosis.
Many authors have proposed that PAD4 activation results from
an increase in intracellular calcium concentration. This passive
model of PAD4 regulation implies that any spike in intracellu-
lar calcium, such as may result from a break in the membrane
barrier of neutrophils, would activate PAD4. The model is con-
sistent with the strong activation of PAD4 by ionophore and
ionomycin (Figure 1C). However, our results demonstrate that
PAD4 activation is not a direct outcome of elevated levels of
intracellular calcium. Even in the presence of elevated cytoplas-
mic calcium, PMA was capable of repressing deimination. This
suggests that neutrophils possess a PMA-responsive mechanism
that inhibits PAD4 activation. Under physiologic conditions, this
PKC-dependent pathway may prevent the premature activation
of PAD4. A PKC isoform that blocks deimination is induced
by PMA and calcium and is suppressed by a narrow concentra-
tion range of chelerythrine and sanguinarine. Because a speciﬁc
peptide inhibitor of PKCα/β could overcome PMA repression
of histone deimination, we conclude that PKCα functions as a
repressor of histone deimination. PKCα, by its association with
adhesion receptors (Rucci et al., 2005), may inhibit PAD4 activa-
tion early during the attachment of neutrophils to the endothelium
and may release PAD4 from repression only during later stages of
chemotactic migration.
The most striking ﬁnding of our study is that repression by a
PKC isoform is not the only safeguard preventing histone deimi-
nation by PAD4. In addition, a second PKC isoform is required to
induce histone deimination in response to PMA or LPS. Because
the induction of deimination was prevented by a speciﬁc pep-
tide inhibitor of PKCζ, we conclude that histone deimination
requires activation through PKCζ. PKCζ is a conserved, atypical
isoform of PKC that contributes to various functions in meta-
zoans, ranging fromcell polarity andmigration to innate responses
to infection (Xu and Clark, 1997; Laudanna et al., 1998; Feng
and Longmore, 2005; Nishimura et al., 2005). The remarkable
range of PKCζ regulated functions reﬂects its multiple cellular
locations and interacting partners. In infections, PKCζ mediates
functions of Toll-like receptors (TLR) at the cell surface (Yang et al.,
2011), the assembly of a functional nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidase complex (Dang et al., 2001;
Raad et al., 2009), the activation of latent cytoplasmic nuclear
factor-kappaB (NF-κB) subunits (Duran et al., 2003), and their
association with active chromatin domains (Levy et al., 2011).
From these known PKCζ functions, it follows that PKCζ may have
diverse opportunities to regulate histone deimination.
The PKCζ isoform could activate PAD4 as soon as a suitable
stimulus binds a cell surface receptor. The ζ isoform participates
in the response to N-formyl-methionyl-leucyl-phenylalanine
(fMLP), adhesion, and chemotaxis (Laudanna et al., 1998). Alter-
natively, PAD4 could be activated indirectly, following PKCζ-
assisted assembly of an active NADPH oxidase complex (Raad
et al., 2009). This possibility may link PAD4 activation to the gen-
eration of reactive oxygen. A third possibility is that PKCζ regulates
the translocation of PAD4 into the nucleus, by analogy to the reg-
ulation of LKB1 nuclear localization by PKCζ (Xie et al., 2009).
Even though cytoplasmic and nuclear pools of PAD4 may coexist,
it is unknown whether PAD4 redistributes following stimulation.
A fourth possibility is that PKCζ regulates PAD4 activity by altering
the structure of chromatin or its interactions with enzymes that
establish the histone epigenetic code (Wang et al., 2010). These
alternatives are now amenable to experimentation.
It is remarkable that histone deimination is regulated by two
PKC isoforms. This indicates that granulocytes precisely control
PAD4 activation and that NETosis depends on a speciﬁc set of
circumstances. Our results further emphasize that evolutionary
pressure ensures histone deimination is closely regulated by an
ancient family of kinases that coordinate numerous other cellu-
lar responses to environmental conditions. Thus, it is no longer
conceivable that NETosis is a random or accidental event. Rather,
NETosis is a fundamental response to a challenge to the survival
of the organism.
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